WallStreetZenWallStreetZen

NASDAQ: IBRX
Immunitybio Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Immunitybio revenue was $82.56M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $32.1M, up 21.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IBRX annual revenue was $14.7M, with 2,270.6% growth year-over-year.

IBRX past revenue growth

How has IBRX's revenue growth performed historically?

Company
1,025.95%
Industry
284.61%
Market
22.91%
IBRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IBRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IBRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IBRX revenue history

Current Revenue
$82.6M
Current Earnings
-$348.6M
Current Profit Margin
-422.3%

Be the first to know when IBRX announces revenue.

IBRX Revenue History By Year

IBRX Yearly RevenueIBRX RevenueIBRX ChangeIBRX Revenue Growth
2024-12-31$14.75M$14.12M+2,270.58%
2023-12-31$622.00k$382.00k+159.17%
2022-12-31$240.00k-$694.00k-74.30%
2021-12-31$934.00k$329.00k+54.38%
2020-12-31$605.00k-$1.60M-72.52%
2019-12-31$2.20M$2.16M+4,585.11%
2018-12-31$47.00k$2.00k+4.44%
2017-12-31$45.00k$1.00k+2.27%
2016-12-31$44.00k-$192.00k-81.36%
2015-12-31$236.00k-$405.00k-63.18%
2014-12-31$641.00k$41.00k+6.83%
2013-12-31$600.00kN/AN/A

1 of 1

Immunitybio Revenue FAQ

What was IBRX's revenue last quarter?

On Invalid Date, Immunitybio (NASDAQ: IBRX) reported Q3 2025 revenue of $32.06 million up 425.07% year over year. In the same quarter last year, Immunitybio's revenue was $6.11 million.

What was Immunitybio's revenue in 2024?

Immunitybio's annual revenue for the twelve months ending Dec 31, 2024 was $14.75 million, a 2,270.58% increase year over year.

How much does Immunitybio make in a day?

Based on Immunitybio annual revenue for the past five years, IBRX makes an average of $9,395.07 per day.

What was Immunitybio's annual revenue growth in the past year?

As of Q4 2025, Immunitybio's revenue has grown 1,025.95% year over year. This is 741.35 percentage points higher than the US Biotechnology industry revenue growth rate of 284.61%. Immunitybio's revenue in the past year totaled $82.56 million.

How much does Immunitybio make in a year?

Immunitybio's revenue by year for the past five years is:
  • Immunitybio's revenue for the twelve months ending Dec 31, 2024 was $14.75 million, a 2,270.58% increase year over year.
  • Immunitybio's annual revenue for Dec 31, 2023 was $622.00 thousand, a 159.17% increase from 2022.
  • Immunitybio's annual revenue for 2022 was $240.00 thousand, a 74.3% decrease from 2021.
  • Immunitybio's annual revenue for 2021 was $934.00 thousand, a 54.38% increase from 2020.
  • Immunitybio's annual revenue for 2020 was $605.00 thousand, a 72.52% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.